Form 4 for TECH Bio-Techne
Accepted 2021-09-24 00:00:00 ET · period of report 2021-09-22 · accession 0000914190-21-000374 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-24 | 2021-09-22 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | S - Sale | $529.04 | -822 | 0 | -100% | -$434.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-22 | S | D | 822 | $529.04 | 0 | D | — | — |